Did you always plan to stay on the same project all the way through your program? What advantages did it give you to have worked on the same research for the whole program?
Apps: Once I really understood what this foam project was about, I knew it would be fascinating to remain as long as I could. By no means am I an expert, but after four years, I have developed substantial knowledge of working in an undergraduate lab and specific knowledge on tumor ablation, foam creation and what all goes into undergraduate research.
Cunningham: It was rewarding to see some of the longer-term results of my work when staying on the project for all of my time. I also developed close relationships with other researchers and with Dr. Glogowski, which have been incredibly valuable.
What do you see as the major project milestones achieved by your team?
Apps: A major step in the process was finally establishing the exact combination of materials and best method for creating the foam. That was an exciting hurdle to clear. That cleared the way for our Mayo collaborator, Dr. McBride, to begin using the foam for in-vivo porcine studies.
Haus: Marshall and I attended the Academic Grand Rounds research event with Mayo Clinic Health System, where we described our research project to clinicians. While it was daunting, I felt incredibly respected by everyone who attended, and they were intrigued by our project.
Another presentation Marshall and I did was called Posters on the Hill, a Washington, D.C., event through the National Council on Undergraduate Research (NCUR), where we presented to Wisconsin legislative representatives about our project and the significance of undergraduate research to a successful college career.
This will remain an ongoing research project, as you know. What will you miss about this team and seeing the realization of the hopes for the foam product?
Apps: I will for sure miss being part of the foam team. Although I won’t be able to see its use in human trials and clinical use, knowing that I was a part of this project that will eventually reach those steps is still very exciting. The current students on the project have already made excellent progress and I know they will continue to do so, and hopefully soon they can see the project race over the finish line.
Cunningham: I will miss being part of this team. I plan to check in and see where things are with the project down the road, and keep an eye out for any updates. In a sense, however, research is never really done, so it comes with the territory. There’s always more to discover and more to learn. Overall, it's just rewarding to know that I was able to be a part of it and others will continue furthering our important work.
Haus: While I am sad to complete my time on the “foam team,” I have the utmost confidence that the younger students will keep making progress and make me proud. As I know research is an ongoing process and it’s never ending, I feel that I will be chasing results for the rest of my career. I’m proud to say I’ve made some impact on this novel project; working on something that will eventually help people feels amazing.
What would you say are the most lasting lessons you will take from your time among the first-ever Blugold Biomedical Innovator Scholars?
Apps: I’ve learned so much from Dr. Glogowski, like critical problem-solving. Looking systemically at a problem like a failed experiment is a great skill that I’ve brought into working in my biology and chemistry labs, as well as just thinking things through logically in my life.
My time in this lab has also taught me leadership. There have been many new researchers in the lab, and I have enjoyed guiding them into the work we do. It has been great to see how they evolve as researchers and really come into their own on the team.
Cunningham: The biggest lesson I've learned is how to confidently bounce ideas back and forth with peers. Dr. Glogowski has been fantastic at providing supported learning but letting us work together and brainstorm, and bring our own skills and ideas to the table.
Haus: I have gained significant skills in public speaking and communicating scientific work to a variety of audiences, assets that will be important in my career. But one bigger lesson stands out for me.
Dr. G. told us that we should always say yes to new opportunities, and not be afraid to try something new, even when we are not certain we know how. That is a lesson I will carry into my biomedical industry career. Saying yes to this research got me interested in a biomedical engineering career in the first place.